Maternal complications in eclampsia and pre-eclampsia: an institutional study

Harsha Konnur, Shilpa Modi


Background: Preeclampsia and eclampsia are associated with higher rates of maternal, fetal, and infant mortality, and severe morbidity, especially in cases of severe preeclampsia, eclampsia, and HELLP syndrome. The aim of the study was to determine maternal outcomes in pregnant women with severe preeclampsia and eclampsia.

Methods: This was a retrospective descriptive study carried out at Vaatsalya Life Hospital, a tertiary hospital in Kalaburagi, Karnataka from January 2016 to June 2018. All patients admitted with preeclampsia and eclampsia were analysed for the maternal complications.

Results: A total of 100 deliveries were conducted during the study period of which 71 cases were severe preeclampsia and eclampsia. Most of the patients were primi parous with mean age of 26.5 years. There were 32 cases of severe preeclampsia and 39 cases of eclampsia. The most common complication was HELLP syndrome in 6 cases (2 with ARF). There was one case of maternal mortality.

Conclusions: We conclude that severe preeclampsia and eclampsia are associated with higher rates of maternal severe morbidity and that these two factors still remain the major contributors to maternal morbidity and mortality.


ARDS, eclampsia, HELLP, Renal failure Pre-eclampsia

Full Text:



Ngwenya S. Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. Int J Women’s Health. 2017;9:353-357.

Oyston CJ, Stanley JL, Baker PN. Potential targets for the treatment of preeclampsia. Expert Opin Ther Targets. 2015;19(11):1517-30.

Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiology. Cardiovasc J Afr. 2016;27(2):71-8.

Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health. 2014;2(6):e323-33.

Ngwenya S. Postpartum haemorrhage: incidence, risk factors, and outcomes in a low resource setting. Int J Women’s Health. 2016;8:647-50.

Nankali A, Malek-khosravi S, Zangeneh M, Rezaei M, Hemati Z, Kohzadi M. Maternal Complications Associated with Severe Preeclampsia. J Obstet Gynaecol India. 2013;63(2):112-5.

Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best practice and research Clinic Obstet Gynaecol. 2011;25(4):391-403.

Turner JA. Diagnosis and management of preeclampsia: an update. Int J Women’s Health. 2010;2:327-37.

Zuberi NF, Arif K, Khan FM, Pal JA. A comparison of severe pre-eclampsia/eclampsia in patients with and without HELLP syndrome. J Pak Med Assoc. 1998;48(2):29-32.

Kinay T, Kucuk C, Kayikcioglu F, Karakaya J. Severe preeclampsia versus HELLP syndrome: maternal and perinatal outcomes at <34 and ≥34 weeks’ gestation. Balkan Med J. 2015;32(4):359-363.

Ananth CV, Lavery JA, Friedman AM, Wapner RJ, Wright JD. Serious maternal complications in relation to severe pre‐eclampsia: a retrospective cohort study of the impact of hospital volume. BJOG: Int J Obstet Gynaecol. 2017;124(8):1246-53.

WHO U. UNFPA, The World Bank and the United Nations Population Division. Trends in maternal mortality. 1990;2013:1-68.

Ghimire S. Eclampsia: feto-maternal outcomes in a tertiary care centre in Eastern Nepal. JNMA J Nepal Med Assoc. 2016;54(201):24-8.

Imarengiaye CO, Isesele TO. Intensive care management and outcome of women of women with hypertensive diseases of pregnancy. Niger Med J. 2015;56(5):333-7.

Paauw ND, Luijken K, Franx A, Verhaar MC, Lely AT. Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clin Sci (Lond) 2016;130(4):239–246.

Robillard PY, Dekker G, Iacobelli S, Chaouat G. An essay of reflection: Why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology? J Reproduct Immunol. 2016;114:44-7.

Iacobelli S, Bonsante F, Robillard PY. Pre-eclampsia and preterm birth in Reunion Island: a 13 years cohort-based study. Comparison with international data. J Matern Fetal Neonatal Med. 2016;29(18):3035–40.

Duley L, Golmezoglu AM, Chou D. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2010;9:CD002960.